Related Experiment Videos
Left ventricular failure with labetalol
Postgraduate Medical Journal
|September 1, 1979
Summary
Labetalol, used for hypertension, can cause heart failure due to its stronger beta-blocking effects. Discontinuing labetalol and managing blood pressure with other agents led to symptom regression, highlighting the need for caution in at-risk patients.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Hypertension management often involves medications with varying mechanisms.
- Labetalol is a dual-acting antihypertensive agent with both alpha- and beta-blocking properties.
Observation:
- A patient receiving labetalol for hypertension developed signs of left ventricular failure.
- The patient's cardiac symptoms improved after labetalol was discontinued.
- Blood pressure was effectively managed using alternative antihypertensive agents.
Findings:
- The adverse cardiac event was potentially linked to the pronounced beta-blocking activity of labetalol compared to its alpha-blocking effects.
- Withdrawal of labetalol resulted in the regression of heart failure symptoms.
Implications:
- Clinicians should exercise caution when prescribing labetalol to patients with pre-existing or symptomatic heart failure.
- The balance of alpha- and beta-adrenergic blockade in labetalol necessitates careful patient selection, particularly in those with compromised cardiac function.